REBIOTIX MICROBIOTA RESTORATION THERAPY A FERRING COMPANY
Dead / Abandoned — Abandoned — no statement of use filed (as of 01 Mar 2021)
What this means for you
This application is over — abandoned 01 Mar 2021. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88276726
- Mark type
- Design + words
- Filed
- 25 Jan 2019
- Published for opposition
- 03 Dec 2019
- Abandoned
- 01 Mar 2021
- Attorney of record
- Michael T. Hess
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical and biopharmaceutical agents used for the treatment of diseases and disorders emanating from microbiota dysfunction; pharmaceutical and biopharmaceutical agents used for the treatment of diseases and disorders in the fields of gastroenterology, reproductive health, metabolic health, endocrinology; pharmaceutical and biopharmaceutical agents used for the treatment of gastrointestinal, infectious, metabolic, liver, inflammatory and neurological diseases and disorders
- Class 042 — Scientific and technological services: medical and scientific research; providing medical and scientific research information in the field of clinical trials
Owner
- REBIOTIX, INC., Roseville, MN, US
- REBIOTIX, INC., Roseville, MN, US
Prosecution history
- 01 Mar 2021 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 01 Mar 2021 — ABANDONMENT - NO USE STATEMENT FILED
- 23 Jul 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 21 Jul 2020 — SOU EXTENSION 1 GRANTED
- 21 Jul 2020 — SOU EXTENSION 1 FILED
- 21 Jul 2020 — SOU TEAS EXTENSION RECEIVED
- 28 Jan 2020 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 03 Dec 2019 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 03 Dec 2019 — PUBLISHED FOR OPPOSITION
- 13 Nov 2019 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 24 Oct 2019 — ASSIGNED TO LIE
- 18 Oct 2019 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 16 Oct 2019 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 16 Oct 2019 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 16 Oct 2019 — TEAS RESPONSE TO OFFICE ACTION RECEIVED